IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Foster Wheeler Receives Contract for API Plant Conversion in the U.K.

7:24 AM MDT | July 17, 2012 | Sotirios Frantzanas

Foster Wheeler says that one of its global engineering and construction group subsidiaries has been awarded an engineering, procurement, and construction management (EPCM) services contract by Epax Pharma U.K. (Middlesbrough, U.K.), a subsidiary of Trygg Pharma (Oslo). Foster Wheeler will convert parts of the former Lundbeck pharmaceutical plant at Seals Sands, U.K., under the terms of the EPCM services contract, to enable the production of an omega-3 active pharmaceutical ingredient (API) from fish oil. Financial terms of the contract were not disclosed. The...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa